PET-TC in Thyroid Evaluation

Enrolling by invitationOBSERVATIONAL
Enrollment

418

Participants

Timeline

Start Date

October 14, 2024

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2029

Conditions
Medullary Thyroid CarcinomaHyperparathyroidismParathyroid Carcinoma
Interventions
OTHER

clinical practice drug treatment

Observational, prospective and retrospective study, transversal, non-profit, monocentric. All data of patients affected/ afferents to theU.O. of Nuclear Medicine of the IRCCS AOU of Bologna will be collected submitted/ who will undergo a PET/ CT investigation for thyroid pathology or other indication with incidental feedback of thyroid uptake and patients who have They undergo PET/CT with known thyroid disease. Of these patients will be collected the personal data, clinical news, data related to PET/ CT (dedicated software e.g. MIM), biochemical/ laboratory and anatomopathological (for operated patients), any other imaging investigations already performed and to be performed later by normal clinical practice. The medical nuclear images will be evaluated by at least two nuclear medical experts, with qualitative, semi-quantitative and radiometric parameters as far as possible. Patients will be treated according to normal clinical practice.

Trial Locations (1)

38050

Nuclear medicine, IRCCS, Azienda Ospedalierio-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER